Oxartis hosts Entrepreneurial Biotechnology Insights visit by eMBA cohort

Oxartis was honoured to participate in an Oxford Prospects eMBA programme on Saturday, by hosting an afternoon in our laboratory for a combination of Lecture and demonstrations. The afternoon was held to be a instructive opportunity for delegates to see the progress of a start-up biotech company.

L-R: Oxartis’s Dr Dye presenting the startup journey tothe eMBA cohort; Dr Nauman Jalil showing our scanning electron microsope in use; Dr Tony Keirouz engaging the delegates in Tissue Scaffold technology.

Oxartis takes on two MSc Reasearch Projects in collboration with UCL

Through our collaboration with UCL Eastman Dental Institute, Oxartis is taking on two MSc Nanotechnology and Regenerative Medicine research projects, focused on characterising particular functional and safety aspects of PMBD material.

Oxartis Team Presents at Advanced Therapies March 2024

The Oxartis team attended and presented their latest development work at Advanced Therapies 2024. This was a fruitful gathering bringing commercial and research organizations together to map future development paths for our pipeline products.

Oxartis wins an IUK RTC award for clean-room manufacturing

8th August 2024

Oxartis has signed an agreement to collaborate with MTIF, Medical Technology Innovation Facility, Nottingham Trent University, to initiate cleanroom manufacture of ProMatrix BioDerm, our first tissue regeneration product, for scarless reconstruction of full-thickness skin loss wounds.

OXARTIS TEAMS UP WITH UCL FOR INNOVATE UK BIOMEDICAL CATALYST PROJECT

Oxartis in partnership with UCL, are launching a landmark product development project supported by an IUK Biomedical Catalyst grant. The grant provides £630,000 of a total project cost of £860,000, to support the pre-clinical development of ProMatrix BioDerm, Oxartis’ lead tissue scaffold product. The collaboration with Dr Linh Nguyen, at the Eastman Dental Institute at University College Hospital, will support the development with some of the nation’s top expertise and technology.

These grants are incredibly competitive, and we are delighted to have been selected as winners. Although it is tough to raise co-funding at an early stage of product development, we are honoured to be able use IUK support to address an urgent un-met clinical need for effective skin reconstruction.

Securing this grant funding has enable Oxartis to establish a laboratory facility at Heyford Park Innovation Centre in the Oxfordshire technology belt, and start work on developing its first clinical product.

OXARTIS WINS BIOKICKSTART COMPETITION

OXARTIS WINS THE OXFORD INNOVATION SPACE BIO KICKSTART COMPETITION 2023

We are delighted to announce that Oxartis was selected as this year’s Bio Kick Start Winner, after a probing pitch and interview contest. Our prize is One year of free laboratory space for a researcher in Heyford Park Innovation Centre, which provides service Laboratory and office space for start up companies.

The prize is sponsored by a number of companies supporting the local startup ecosystem, which is a great help in launching our laboratory operations.

Oxartis joins the Panacea Stars Develop Accelerator

We are honoured and delighted to be selected for the Oxford-based Panacea Stars Accelerator Programme, running through November and December 2022. We have already participated in an entrepreneurs bootcamp, and gained many insights from formal talks and mentoring sessions.

Oxartis selected for the TechTour Health21 Season

Oxartis was selected as one 30 companies from 200 applicants to participate in the TechTour Health 21 Investor pitching and networking events. The Key opening event took place on 27/26th October 2021 within the new Bio-pole Innovation park in Lausanne, and other online events during November.

The TechTour prooved to be a great forum for making introductions to relevant Investors, as well as networking and sharing ideas and experiences with fellow entrepreneurs in Biotech sector.

OxLEP eScalate development grant

14th October 2020

eScalate Business grant won from OxLEP with the European Regional Development Fund

We are delighted to have secured an eScalate OxLEP grant from the ERDF. This funding will significantly help Oxartis to strengthen its core company structure through a series of profession consultations, and to leverage its existing position. OxLEP, the Oxford Local Enterprise Programme, offers great opportunities to technology companies to establish and grow within the Oxford ecosystem.

Oxfordseed competition

26th June, 2020

Dr Dye’s team wins 3rd place in OxfordSeed 2020 start-up competition run by the Said Business School, University of Oxford.

The competition was run from March to June 2020, and the ProMatrix venture was shortlisted from over 100 start-ups, across all sectors.